Methotrexate (MTX) is used as an anchor disease-modifying anti-rheumatic drugs
(DMARDs) in treating rheumatoid arthritis (RA) because of its potent efficacy and tolerability …

Methotrexate (MTX) is significantly more effective than and has a considerable advantage
over placebo in patients with severe and persistent rheumatoid arthritis (RA). The drug is …

Objectives Since the 2007 recommendations for the management of early arthritis have
been presented, considerable research has been published in the field of early arthritis …

Methotrexate (MTX) is one of the most effective and widely used drugs in the management of
autoimmune and dermatological diseases. Rheumatoid arthritis and psoriasis patients who …

Objectives To develop EULAR recommendations for screening and prophylaxis of chronic
and opportunistic infections in patients with autoimmune inflammatory rheumatic diseases …

Objective Because of the expected increase in the number of dementia patients, the
unlikelihood of a cure in the near future, and the rising cost of care, there is an increasing …

Objective: To perform a systematic literature review of the long-term safety of methotrexate
(MTX) monotherapy in rheumatoid arthritis (RA). Methods: A search was performed in …

We aimed to develop evidence-based multinational recommendations for the diagnosis and
management of gout. Using a formal voting process, a panel of 78 international …

There is a large body of evidence to suggest that improving periconceptional folate status
reduces the risk of neonatal neural tube defects. Thus increased folate intake is now …

Background: Treatment strategies for tight control of early rheumatoid arthritis (RA) are
highly effective but can be improved. Objective: To investigate whether adding prednisone …